pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jul 20·1 min read
save

Fugitive ex-doctor arrested after two decades posing as biotech executive

Jul 20, 2026·read at STAT ↗RegulatoryNegative

Federal and Rhode Island authorities arrested Ronald Fischer, 70, after tracking a 56-foot sailboat off New Jersey. He had been on the run for about 20 years.

Fischer, a former anesthesiologist, vanished in 2005 while on trial for first-degree sexual assault. He used the alias Richard Graydon, which was also listed as the registered owner of the boat.

Under that alias he was hired in March by Immix as a drug development executive. The arrest raises questions about background checks in biotech firms but does not affect any specific drug programs.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: A most-wanted fugitive appears to have been secretly working as a biotech executive”

read at STAT ↗
522 words · retrieved Jul 20
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
ELI LILLY COLILLY
topics
Gene Therapy (AAV)Small Molecule

related stories

  • 7h agoNovartis may cut around 130 in Switzerland while relocating biologics productionBioSpace
  • Jul 21STAT+: Anthropic deepens work with rare disease drugsSTAT
  • Jul 17STAT+: The end for GSK’s chronic cough treatmentSTAT
  • Jul 17STAT+: Can ultrasound unlock the power of gene therapy? A startup makes big claimsSTAT
  • Jun 29FDA Selects Seven Participants for PreCheck Pilot Program to Advance U.S. Drug Manufacturingfda press